Journal of Clinical Oncology , 0732-183X

Journal

1 - 10 out of 111Page size: 10

Publications

  1. 2019
  2. Published

    Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study

    Kristian Brock, Sam Munoz Vicente, Becky Boucher, 20 Oct 2019, In : Journal of Clinical Oncology . 37, 30, p. 2722-2729 8 p.

    Research output: Contribution to journal › Article

  3. Published

    Trans-aTTom: Breast Cancer Index for prediction of endocrine benefit and late distant recurrence (DR) in patients with HR+ breast cancer treated in the adjuvant tamoxifen—To offer more? (aTTom) trial.

    Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, 20 May 2019, In : Journal of Clinical Oncology. 37, 15_suppl, p. 505 1 p.

    Research output: Contribution to journal › Abstract

  4. Published

    Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

    Charles Craddock, Daniel Slade, Carmela De Santo, Rachel Hoare, Kristian Brock, Francis Mussai & Christina Yap, 1 Mar 2019, In : Journal of Clinical Oncology . 37, 7, p. 580-588 9 p., JCO1800889.

    Research output: Contribution to journal › Article

  5. 2018
  6. E-pub ahead of print

    High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-E.W.I.N.G.99 and Ewing-2008

    6 Sep 2018, In : Journal of Clinical Oncology . 16 p.

    Research output: Contribution to journal › Article

  7. E-pub ahead of print

    Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

    Keith Wheatley, 28 Aug 2018, In : Journal of Clinical Oncology .

    Research output: Contribution to journal › Article

  8. E-pub ahead of print

    Risk, risk factors and surveillance of subsequent malignant neoplasms in childhood cancer survivors: a review

    Raoul Reulen, 6 Jun 2018, In : Journal of Clinical Oncology . 36, 9 p.

    Research output: Contribution to journal › Article

  9. E-pub ahead of print

    Development and validation of a combined metabolic and immune prognostic classifier for head and neck cancer

    Jill Brooks, Lucinda Archer, Rachel Spruce, Nikos Batis, Jennifer Bryant, Andrew Beggs, Daniel Tennant, Gary Middleton, Jean-Baptiste Cazier, Benjamin Willcox, 1 Jun 2018, In : Journal of Clinical Oncology. 36, 15 Suppl, p. 6049-6049

    Research output: Contribution to journal › Abstract

  10. Published

    Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

    & 12 others, , Daniel Rea, 1 Apr 2018, In : Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.

    Research output: Contribution to journal › Article

  11. E-pub ahead of print

    Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in standard- risk patients without NPM1 mutations

    Sylvie Freeman, Naeem Khan, 30 Mar 2018, In : Journal of Clinical Oncology .

    Research output: Contribution to journal › Article

  12. E-pub ahead of print

    Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial

    Pamela Kearns, 2 Mar 2018, In : Journal of Clinical Oncology . 11 p., JCO2017759597.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...12 Next